[PDF] Top 20 Estudio sobre los Factores que Influyen en la Pérdida de Interés Hacia las Matemáticas
Has 10000 "Estudio sobre los Factores que Influyen en la Pérdida de Interés Hacia las Matemáticas" found on our website. Below are the top 20 most common "Estudio sobre los Factores que Influyen en la Pérdida de Interés Hacia las Matemáticas".
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.
... all patients after the first cycle of ...between patients. Nine of 14 patients (64%) showed a response after the first treatment ...nine patients were eligible for a second therapeutic ... See full document
7
Potential role of <sup>124</sup>I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer
... Abstract: Renal cell carcinoma (RCC) is a biologically heterogeneous disease, with many small renal masses (SRMs) exhibiting an indolent natural history, while others progress more rapidly to ... See full document
80
Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study
... 115,000 patients are diagnosed with renal cell carcinoma (RCC) in Europe every year ...these patients is treated by nephron-sparing surgery (NSS) with a trend towards NSS of larger or ... See full document
26
Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX
... resistance. Carbonic anhydrase IX (CA-IX) has been advocated as an attractive diagnostic and therapeutic biomarker for targeting hypoxia in solid ...cancer cell survival under low ... See full document
11
Amatuximab and novel agents targeting mesothelin for solid tumors
... Although, in recent decades, it has been possible to increase the OS or PFS in many patients, some types of cancer remain a concrete challenge for modern oncology. Important factors such as the difficulty of ... See full document
8
Carbonic anhydrase IX enhances tumor cell proliferation and tumor progression in osteosarcoma
... CA IX (M75; mouse mono- clonal antibody; ...CA IX was evaluated ...CA IX was assessed by two parameters – the stained nuclear area of tumor cells (0–3 points) and the intensity of staining ... See full document
7
The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment
... The HGF-MET axis is frequently dysregulated in cancer, especially in advanced or metastatic disease. Upregulation of the HGF-MET axis can promote resistance to small molecule inhibition of several important ... See full document
34
Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy
... those patients in the peme- trexed alone group were allowed for crossover to receive ...randomized study that showed a benefit of a triplet regimen over doublet ...double-blind, phase 3 studies, ... See full document
18
Anti-PD-1 monoclonal antibody MEDI0680 in a phase I study of patients with advanced solid malignancies
... other anti-PD-1 clinical trials [46, ...oma patients treated with nivolumab and found changes indicative of natural killer (NK) cell expansion and cyto- lytic function that included upregulation of ... See full document
98
Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls
... HIF-1alpha, renal cell carcinoma, and p53 signaling, regulation of epithelial to mesenchymal transition, and neuroinflam- mation signaling (Additional file ... See full document
25
The current status of immunobased therapies for metastatic renal-cell carcinoma
... thawing phase, the extracellular ice melts first, causing an osmotic imbalance that results in fluid shift intracellularly, cellular swelling, and ...necrotic cell death has long been considered to be more ... See full document
5
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
... The study was performed in accordance with REMARK cri- teria ...of patients (elevated/non- elevated CTC and serum markers) were compared using the log-rank test to evaluate whether there is a difference in ... See full document
11
THE EFFECT OF INTRAVENOUSLY ADMINISTERED 6063, THE CARBONIC ANHYDRASE INHIBITOR, 2 ACETYLAMINO 1,3,4 THIADIAZOLE 5 SULFONAMIDE, ON FLUID AND ELECTROLYTES IN NORMAL SUBJECTS AND PATIENTS WITH CONGESTIVE HEART FAILURE
... K., and Halpern, M., Effect of carbonic anhydrase inhibitor 6063 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide on renal excretion of fluid and electrolytes in patients with congestive he[r] ... See full document
123
Effects of stimulating interleukin -2/anti- interleukin -2 antibody complexes on renal cell carcinoma
... of patients [13, 14]. Blockade of CTLA4, a T-cell inhibitory receptor with ipilimumab, and in- creasing T-cell proliferation and cytotoxic effects with PD-1/PD-L1 axis inhibition also induced ... See full document
69
Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma
... Mantle cell lymphoma (MCL) is a rare and aggressive subtype of lymphoma associated with a poor ...for patients with this ...of patients relapse within a few years of ...integrating cell ... See full document
23
Surgery for retrohepatic caval thrombus in patients with advanced renal cell carcinoma: a case series
... From 2007 to 2014, a cohort of 20 patients with RCC- related venous thrombus in the retrohepatic portion of the inferior vena cava (IVC) underwent surgical thromb- ectomy. Diagnosis was established through ... See full document
8
Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma
... retrospective study looking at baseline features predictive of survival in untreated patients with metastatic RCC treated in seven American and Canadian cancer ...645 patients were included, of whom ... See full document
13
Signal transducer and activator of transcription 3 in myeloid- derived suppressor cells: an opportunity for cancer therapy
... and anti-VEGF antibodies demonstrated no effect on MDSC levels in peripheral blood of cancer patients ...that anti-VEGF antibodies successfully reduce MDSC numbers in mice ...developed ... See full document
34
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors
... cancer cell proliferation in these ...tumor cell proliferation in non-hypoxic zones (HT29: vehicle ...no anti-proliferative effect of rapamycin on cancer cells cultured in hypoxic conditions (1 % ... See full document
23
Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients
... this study, we obtained 70 surgical tissue samples from the 76 registered RCC ...normal renal tissues were used as negative ...in anti-EpCAM antibody (dilution 1:200; ZSGB, Beijing, China), ... See full document
110
Related subjects